Diabetes control in patients given corticosteroids;Prise en charge du diabete lors d'une corticotherapie

Presse Medicale

Volumn 29, Issue 5, 2000, Pages 263-266

  Jannot Lamotte, M F ^a   Raccah, D ^a  

^a TIMONE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA GLUCOSIDASE INHIBITOR; BETAMETHASONE; BIGUANIDE DERIVATIVE; CORTICOSTEROID; CORTISONE; CORTIVAZOL; DEXAMETHASONE; DEXAMETHASONE SODIUM PHOSPHATE; GLUCOSE; HYDROCORTISONE; INSULIN; METHYLPREDNISOLONE; METHYLPREDNISOLONE SODIUM SUCCINATE; ORAL ANTIDIABETIC AGENT; PARAMETHASONE; PARAMETHASONE ACETATE; PREDNISOLONE; PREDNISOLONE 3 SULFOBENZOATE; PREDNISONE ACETATE; TRIAMCINOLONE; TRIAMCINOLONE HEXACETONIDE; GLUCOCORTICOID; PREDNISONE;

CORTICOSTEROID THERAPY; DIABETES CONTROL; DRUG CONTRAINDICATION; GLUCOSE BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; KETOACIDOSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; REVIEW; ADULT; BLOOD; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; DIABETES MELLITUS; DOUBLE BLIND PROCEDURE; INSULIN RESISTANCE; RANDOMIZED CONTROLLED TRIAL; TIME;

ADULT; BLOOD GLUCOSE; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DOUBLE-BLIND METHOD; GLUCOCORTICOIDS; HUMANS; INSULIN; INSULIN RESISTANCE; PREDNISONE; RANDOMIZED CONTROLLED TRIALS; TIME FACTORS;

EID: 0034639653     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (38)

1. Lechat P. Chimie et pharmacologie ces glucostéroïdes. Revue de Stomatologie 1975 ; 76:353-61.
2. Shamoon H, Soman V, Sherwin RS. The influence of accute physiological increments of cortisol on fuel metabolism and insulin binding to monocytes in normal humans. J Clin Endocrinol Metab 1980 ; 50:495.
3. Kraus-F-iedmam N. Hormonal regulation of hepatic gluconeogenesis. Physiol Rev 1984 ; 64:170.
4. Caro JF, Arnahuda J. Clucocorticoïd-induced insulin resistance. J Clin Invest 1982 ; 69:866.
5. Grumfeld C, Baird K, Van Obberghen E. Glucocorticoïd-induced insulin resistance in vitro: Evidence for both receptor and post receptor defects. Endocrinology 1981 ; 109:1723.
6. Tappy L, Randin D, Vollenweider P et al. Mechanisms of Dexamethasone-Induced Insulin Resistance in Healthy Humans. J Clin Endocrinol Metab 1994 ; 79:1063-9.
7. Mc Mahon M, Gerich J, Rizza R. Effects of glucocorticoïd on carbohydrate metabolism. Diabetes Metab Rev 1988 ; 4:17-30.
8. Delaunay F, Khan A, Cintra A et al. Pancreatic beta cells are important target for the diabetogenic effects of glucocorticoids. J Clin Invest 1997 ; 100:2094-8.
9. Arner P, Gunnarsson R, Blomdahl S. Some characteristics of steroid diabetes: A study in renal transplant recipients receiving high-dose corticosteroid therapy. Diabetes Care 1983 ; 6:23.
10. Hrick DE, Bartucci MR, Mois EJ. Effects of steroid withdrawal on post transplant diabetes mellitus in cyclcsporine-treated renal transplant recipients. Transplantation 1991 ; 51:374.
11. Ruiz JC, Simmons RL, Callender CO. Stero d diabetes in renal transplant recipents. Pathogenic factors and prognosis. Surgery 1973 ; 73:759-65.
12. Veenstra DL, Best JH, Hornberger J, Sullivan SD, Hricik DE. Incidence and long term cost of steroid-related side effects after renal transplantation. Am J Kidney Dis 1999 ; 33:829-39.
13. Gurwitz JH, Bohn RL, Glynn RJ, Monane M, Mogun H, Avorn J. Glucocorticoids and the risk for initiation of hypoglycemic therapy. Arch Intern Med 1994 ; 154:97-101.
14. Raul Ariza-Andraca C, Barile-Fabris LA, Frati-Munari AC, Baltazar-Montufar P. Risk factors for steroid diabetes in rhumatic patients. Arch Med Res 1998 ; 29:259-62.
15. Greenstone MA, Shaw AB. Alternate day corticosteroid causes alternate day hyperglycemia. Postgrad Med J 1987 ; 63:761
16. Davidson NA, Westervelt FB, Bolton WK. Comparison of alternate day steroid and daily steroids in renal transplant recipients. Proc Dial Transplant Forum 1980 ; 10:150-4.
17. Summerskill WHJ, Korman MG, Ammon HV, Baggenstcss AH. Prednisolone for chronic acute liver disease: dose titration, standard dose and continuation with azathioprire compared. Gut 1975 ; 16:876-83.
18. Haggerty RC, Bergsman K, Edelson GW. Steroid-induced diabetic ketoacidosis. Pract Diabetol 1995 ; 14:24-5.
19. Braithwaite SS, Barr WG, Rahman A, Quddusi S. Managing diabetes during glucocorticoid therapy. How to avoid metabolic emergencies. Postgrad Med Diabetes 1993 ; 104:163-76.
20. Bedalov A, Balasubramanyam A. Glucocorticoid-induced ketoacidosis in gestational diabetes: sequela of the acute treatment of preterm labor. A case report. Diabetes Care 1997 ; 20:922-4.
21. Yang JY, Cui XL, He XJ. Non ketotic hyperosmolarcoma complicating steroid treatment in childhood nephrosis. Pediatr Nephrol 1995 ; 9:621-2.
22. Pagano G, Lombardi A, Ferraris GM et al. Acute effect of prednisone and deflazacort on glucose tolerance in prediabetic subjects. Eur J Clin Pharmacol 1982 ; 22:469-71.
23. Bruno A, Cavillo-Perin P, Cassader M, Pagano G. Deflazocort versus prednisolone Effect of blood glucose control in insulin-treated diabetics. Arch Intern Med 1987 ; 147:679-80.
24. Pandit M, Burke J, Gustafson A, Minocha A, Peiris A. Drugs-induced disorders of glucose tolerance. Ann Intern Med 1993 ; 118:529-39.
25. Conn JW, Fajans SS. Influence of adrenal cortical steroids on carbohydrate metabclism in man. Metabolism 1956; 5:114.
26. Dunning T, Corticosteroid medications and diabetes mellitus. Practical Diabetes International 1996 ; 13:186-8.
27. Tauber JP. Insulin analog (Humalog) in discontinuous injections: from pharmacology to clinical use. Diabetes Metabolism 1997 ; 23:50-7.
28. Hirsh IB, Paauw DS. Diabetes management in special situations. Endocrinol Metabol Clin North Am 1997 ; 26:631-45.
29. Tanaka M, Endo K, Suzuki T, Maruyama Y, Kondo A. Treatment for steroid induced diabetes with alpha glucosidase inhibtor, voglibose. Eur J Neurol 1998 ; 5:515.
30. Wechsler B. La corticothérapie générale et ses complications. Rev Prat 1990 ; 40:521-6.
31. Christmann D1 Fasquali JL, Meyer F et al. Corticosteroid-sensitive chemical diabetes in Horton's disease. Nouv Presse Med 1979 ; 8:2735-8.
32. Grimaldi A, Saint Jean O, Bosquet F, Pennaforte S. Guèrison d'un «diabète» par à corticothérapie lors d'une maladie de Norton. Presse Med 1985 ; 14:2152.
33. American Diabates Association. Self-monitoring of blood glucose (consensus statement). Diabetes care 1996 ; 19 (suppl. 1):562
34. Charbonnel B, Boivineau C, Chopinet P et al. Recommandations de l'ALFEDIAM. Auto-surveillance glycémique chez le diabétique. Diabetes & Metabolism 1996 ; 1:31-6.
35. Sjivi du patent diabétique de type 2 à l'exclusion du suivi des complications. Recommandations de L'ANAES. Diabetes & Metabolism 1999 ; 25(suppl 2):26.
36. Suivi du patient diabétique de type 2 à l'exclusion du suivi des complications. Recommandations de L'ANAES. Diabetes & Metabolism 1999 ; 25(suppl 2):9.
37. Suivi du patient diabétique de type 2 à l'exclusion du suivi des complications. Recommandations de L'ANAES. Diabetes & Metobolism 1999 ; 25(suppl 2):10.
38. Cornell RC, Stoughton RB. The use of topical steroids in psoriasis. Dermatologic Clin 1984 ; 2:397-409.